Many expensive cancer drugs have unclear patient benefit

New cancer drugs are being launched at a rapid pace, before their long-term effectiveness for patients can be evaluated. Several years later, most of them still lack scientific evidence for actually increasing life expectancy or improving quality of life.

from Top Health News -- ScienceDaily https://ift.tt/nt2IzFl